BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 33723124)

  • 41. Cannabinoids in clinical practice.
    Williamson EM; Evans FJ
    Drugs; 2000 Dec; 60(6):1303-14. PubMed ID: 11152013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabis: are there any benefits?
    Vickery AW; Finch PM
    Intern Med J; 2020 Nov; 50(11):1326-1332. PubMed ID: 33215831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of cannabinoids in regulation of nausea and vomiting, and visceral pain.
    Malik Z; Baik D; Schey R
    Curr Gastroenterol Rep; 2015 Feb; 17(2):429. PubMed ID: 25715910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.
    Sholler DJ; Huestis MA; Amendolara B; Vandrey R; Cooper ZD
    Pharmacol Biochem Behav; 2020 Dec; 199():173059. PubMed ID: 33086126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoids: Therapeutic Use in Clinical Practice.
    Pagano C; Navarra G; Coppola L; Avilia G; Bifulco M; Laezza C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Δ
    Darmani NA; Belkacemi L; Zhong W
    Eur J Pharmacol; 2019 Dec; 865():172806. PubMed ID: 31738934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Future Aspects for Cannabinoids in Breast Cancer Therapy.
    Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evolution of cannabinoid receptors in cancer.
    Pennant NM; Hinton CV
    WIREs Mech Dis; 2023; 15(4):e1602. PubMed ID: 36750231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of cannabis in supportive care and treatment of brain tumor.
    Likar R; Nahler G
    Neurooncol Pract; 2017 Sep; 4(3):151-160. PubMed ID: 31385997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Terpenoids, Cannabimimetic Ligands, beyond the
    Gonçalves ECD; Baldasso GM; Bicca MA; Paes RS; Capasso R; Dutra RC
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32235333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective.
    Karst M; Wippermann S
    Expert Opin Investig Drugs; 2009 Feb; 18(2):125-33. PubMed ID: 19236260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.
    Hanlon KE; Vanderah TW
    Methods Enzymol; 2010; 484():3-30. PubMed ID: 21036224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Constituents of Cannabis Sativa.
    Rock EM; Parker LA
    Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.